Albrecht Fleckenstein

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Albrecht Fleckenstein

Albrecht Fleckenstein (3 March 1917 – 4 April 1992) was a German pharmacologist and physiologist best known for his discovery of calcium channel blockers.[1][2]

Life and career[edit]

Albrecht Fleckenstein was born on 3 March 1917 in Aschaffenburg, Germany. He received his medical training in Würzburg and Vienna. In 1964, Fleckenstein reported about the inhibitory actions of prenylamine and verapamil on the physiological process of excitation–contraction coupling. This contributed to his discovery of calcium antagonists.[1]


In 1986, Fleckenstein received the Ernst Jung Prize, awarded annually for excellence in biomedical sciences.[3] In 1991, He also received the Albert Einstein World Award of Science.


  1. ^ a b Hurst, J. Willis; Fye, W. Bruce; Acierno, Louis J.; Worrell, L. Timothy (1 December 2004). "Albrecht Fleckenstein: Father of calcium antagonism". Clinical Cardiology. 27 (12): 710–711. doi:10.1002/clc.4960271213. 
  2. ^ Nayler, Winifred G. (1993). "Albrecht Fleckenstein". Cardiovascular Drugs and Therapy. 7 (1): 183–183. doi:10.1007/BF00878328. 
  3. ^ "All Laureates". Ernst Jung Prize. Retrieved 2 September 2013.